To investigate liver tissue alterations across chronic hepatitis B (CHB) progression stages and monitor therapeutic changes following pegylated interferon-α (PEG-IFNα) therapy using T1ρ magnetic resonance imaging (MRI).

Read the full article on ejradiology.com